版本:
中国

BRIEF-Rigel Pharmaceuticals expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017

Oct 7 Rigel Pharmaceuticals Inc

* Expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐